Team
The New Way to protect. prevent.
We are working to change the world with the first universal influenza vaccine.
Meet the Team
-
Arthur Young, PhD
FOUNDER & CEO
Chief inventor and researcher of InvVax's breakthrough vaccine technology.
-
Nima Shiva
BUSINESS DEVELOPMENT
Strong experience with early-stage companies, especially commercializing technologies from universities.
-
Olga Petrauskene, PhD
ADVISOR & DIRECTOR
Biochemist and accomplished life science product development leader with deep experience from research through commercialization.
-
Paul Swartz, PhD
BOARD MEMBER
An investor specializing in bio-technology and current chair of the Life Sciences for Sand Hill Angels.
-
Tyler Tarr
BOARD MEMBER
Financial and operational experience from early stage high tech to large multi-national enterprises.
-
Ian Wilson, PhD
ADVISOR
One of world's leading structural biologists with specialization in influenza and other viruses.
-
Jon Lasch, PhD
ADVISOR
Expert in university technology transfer and commercialization, and financing early-stage biotech companies.
-
Han van den Bosch, PhD
ADVISOR
Expert on vaccine commercialization, Professor chair of "International Public Health and the Pharmaceutical Industry".
-
Jerry Zack, PhD
ADVISOR
Director of the UCLA Center for AIDS Research (CFAR), known for his innovative work on the AIDS virus (HIV).